Healthy Japanese subjects
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Students who belong to an athletic club at Nihon University 2. Men 3. Adults 4. Healthy subjects
Exclusion criteria
Exclusion criteria: 1. Subjects who are undergoing medical treatment or have a medical history of malignant tumor, heart failure, and myocardial infarction 2. Subjects who have a pacemaker or an implantable cardioverter defibrillator (ICD) 3. Subjects currently undergoing treatment for any of the following chronic diseases: cardiac arrhythmia, liver disorder, kidney disorder, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension, or any other chronic diseases 4. Subjects who cannot conduct exercise load due to locomotorium injury or pain (discomfort) 5. Subjects who usually take collagen-health food 6. Subjects currently taking medications (including herbal medicines) 7. Subjects who suffer from COVID-19 8. Subjects who have been enrolled in other clinical trials within the last 28 days before the agreement to participate in this trial or plan to participate another trial during this trial 9. Subjects who are judged as ineligible to participate in this study by the physician
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Collagen degradation products, myoglobin, and creatine kinase (CK) in the blood right and two hours after exercise load 2. Muscle pain measured by visual analogue scale (VAS) 3. Correlation between muscle mass and blood collagen degradation products 4. Correlation between muscle mass and inflammatory markers | — |
Countries
Japan
Contacts
ORTHOMEDICO Inc. R&D Department